学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
AN EXAMINATION OF A POSSIBLE PHARMACOKINETIC INTERACTION BETWEEN NIFEDIPINE AND ANTIPYRINE
被引:6
作者
:
EDEKI, T
论文数:
0
引用数:
0
h-index:
0
机构:
ST BARTHOLOMEWS HOSP,DEPT CLIN PHARMACOL,LONDON EC1A 7BE,ENGLAND
ST BARTHOLOMEWS HOSP,DEPT CLIN PHARMACOL,LONDON EC1A 7BE,ENGLAND
EDEKI, T
[
1
]
JOHNSTON, A
论文数:
0
引用数:
0
h-index:
0
机构:
ST BARTHOLOMEWS HOSP,DEPT CLIN PHARMACOL,LONDON EC1A 7BE,ENGLAND
ST BARTHOLOMEWS HOSP,DEPT CLIN PHARMACOL,LONDON EC1A 7BE,ENGLAND
JOHNSTON, A
[
1
]
TURNER, P
论文数:
0
引用数:
0
h-index:
0
机构:
ST BARTHOLOMEWS HOSP,DEPT CLIN PHARMACOL,LONDON EC1A 7BE,ENGLAND
ST BARTHOLOMEWS HOSP,DEPT CLIN PHARMACOL,LONDON EC1A 7BE,ENGLAND
TURNER, P
[
1
]
机构
:
[1]
ST BARTHOLOMEWS HOSP,DEPT CLIN PHARMACOL,LONDON EC1A 7BE,ENGLAND
来源
:
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
|
1990年
/ 39卷
/ 04期
关键词
:
antipyrine;
interaction;
Nifedipine;
D O I
:
10.1007/BF00315420
中图分类号
:
R9 [药学];
学科分类号
:
1007 ;
摘要
:
The influence of 2 weeks oral intake of nifedipine (2×20 mg) on the oxidative metabolism of antipyrine was investigated in 12 normal volunteers, who had 1050 mg antipyrine solution orally before and after the course of nifedipine. There were no statistically significant differences in the saliva pharmacokinetic parameters of antipyrine on both occasions. However, the metabolite profile of antipyrine in urine showed a significant reduction in the amount of norantipyrine excreted after compared to that before nifedipine administration (16.5 vs 19.6%). This may have implications for drugs that share a similar demethylation pathway with norantipyrine. © 1990 Springer-Verlag.
引用
收藏
页码:405 / 407
页数:3
相关论文
共 24 条
[1]
CHANGES IN ANTIPYRINE AND INDOCYANINE GREEN KINETICS DURING NIFEDIPINE, VERAPAMIL, AND DILTIAZEM THERAPY
BAUER, LA
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WASHINGTON,SCH MED,DEPT MED,DIV CARDIOL,SEATTLE,WA 98195
BAUER, LA
STENWALL, M
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WASHINGTON,SCH MED,DEPT MED,DIV CARDIOL,SEATTLE,WA 98195
STENWALL, M
HORN, JR
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WASHINGTON,SCH MED,DEPT MED,DIV CARDIOL,SEATTLE,WA 98195
HORN, JR
DAVIS, R
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WASHINGTON,SCH MED,DEPT MED,DIV CARDIOL,SEATTLE,WA 98195
DAVIS, R
OPHEIM, K
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WASHINGTON,SCH MED,DEPT MED,DIV CARDIOL,SEATTLE,WA 98195
OPHEIM, K
GREENE, L
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WASHINGTON,SCH MED,DEPT MED,DIV CARDIOL,SEATTLE,WA 98195
GREENE, L
[J].
CLINICAL PHARMACOLOGY & THERAPEUTICS,
1986,
40
(02)
: 239
-
242
[2]
COMPARISON OF THE INVIVO AND INVITRO RATES OF FORMATION OF THE 3 MAIN OXIDATIVE METABOLITES OF ANTIPYRINE IN MAN
BOOBIS, AR
论文数:
0
引用数:
0
h-index:
0
BOOBIS, AR
BRODIE, MJ
论文数:
0
引用数:
0
h-index:
0
BRODIE, MJ
KAHN, GC
论文数:
0
引用数:
0
h-index:
0
KAHN, GC
TOVERUD, EL
论文数:
0
引用数:
0
h-index:
0
TOVERUD, EL
BLAIR, IA
论文数:
0
引用数:
0
h-index:
0
BLAIR, IA
MURRAY, S
论文数:
0
引用数:
0
h-index:
0
MURRAY, S
DAVIES, DS
论文数:
0
引用数:
0
h-index:
0
DAVIES, DS
[J].
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY,
1981,
12
(06)
: 771
-
777
[3]
BREIMER DD, 1984, PHARMACOKINETICS MOD
[4]
DILTIAZEM TREATMENT IMPAIRS HEPATIC DRUG OXIDATION - STUDIES OF ANTIPYRINE
CARRUM, G
论文数:
0
引用数:
0
h-index:
0
机构:
BAYLOR COLL MED,DEPT MED,HYPERTENS & CLIN PHARMACOL SECT,1 BAYLOR PLAZA,SUITE 826E,HOUSTON,TX 77030
BAYLOR COLL MED,DEPT MED,HYPERTENS & CLIN PHARMACOL SECT,1 BAYLOR PLAZA,SUITE 826E,HOUSTON,TX 77030
CARRUM, G
EGAN, JM
论文数:
0
引用数:
0
h-index:
0
机构:
BAYLOR COLL MED,DEPT MED,HYPERTENS & CLIN PHARMACOL SECT,1 BAYLOR PLAZA,SUITE 826E,HOUSTON,TX 77030
BAYLOR COLL MED,DEPT MED,HYPERTENS & CLIN PHARMACOL SECT,1 BAYLOR PLAZA,SUITE 826E,HOUSTON,TX 77030
EGAN, JM
ABERNETHY, DR
论文数:
0
引用数:
0
h-index:
0
机构:
BAYLOR COLL MED,DEPT MED,HYPERTENS & CLIN PHARMACOL SECT,1 BAYLOR PLAZA,SUITE 826E,HOUSTON,TX 77030
BAYLOR COLL MED,DEPT MED,HYPERTENS & CLIN PHARMACOL SECT,1 BAYLOR PLAZA,SUITE 826E,HOUSTON,TX 77030
ABERNETHY, DR
[J].
CLINICAL PHARMACOLOGY & THERAPEUTICS,
1986,
40
(02)
: 140
-
143
[5]
A RANDOMIZED DOUBLE-BLIND CROSSOVER TRIAL OF NIFEDIPINE IN THE TREATMENT OF PRIMARY RAYNAUDS-PHENOMENON
CORBIN, DOC
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL INFIRM EDINBURGH,PERIPHERAL VASC CLIN,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
ROYAL INFIRM EDINBURGH,PERIPHERAL VASC CLIN,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
CORBIN, DOC
WOOD, DA
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL INFIRM EDINBURGH,PERIPHERAL VASC CLIN,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
ROYAL INFIRM EDINBURGH,PERIPHERAL VASC CLIN,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
WOOD, DA
MACINTYRE, CCA
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL INFIRM EDINBURGH,PERIPHERAL VASC CLIN,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
ROYAL INFIRM EDINBURGH,PERIPHERAL VASC CLIN,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
MACINTYRE, CCA
HOUSLEY, E
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL INFIRM EDINBURGH,PERIPHERAL VASC CLIN,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
ROYAL INFIRM EDINBURGH,PERIPHERAL VASC CLIN,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
HOUSLEY, E
[J].
EUROPEAN HEART JOURNAL,
1986,
7
(02)
: 165
-
170
[6]
THEOPHYLLINE METABOLISM IN RELATION TO ANTIPYRINE, DEBRISOQUINE, AND SPARTEINE METABOLISM
DAHLQVIST, R
论文数:
0
引用数:
0
h-index:
0
机构:
FLINDERS UNIV S AUSTRALIA, DEPT CLIN PHARMACOL, BEDFORD PK, SA 5042, AUSTRALIA
DAHLQVIST, R
BERTILSSON, L
论文数:
0
引用数:
0
h-index:
0
机构:
FLINDERS UNIV S AUSTRALIA, DEPT CLIN PHARMACOL, BEDFORD PK, SA 5042, AUSTRALIA
BERTILSSON, L
BIRKETT, DJ
论文数:
0
引用数:
0
h-index:
0
机构:
FLINDERS UNIV S AUSTRALIA, DEPT CLIN PHARMACOL, BEDFORD PK, SA 5042, AUSTRALIA
BIRKETT, DJ
EICHELBAUM, M
论文数:
0
引用数:
0
h-index:
0
机构:
FLINDERS UNIV S AUSTRALIA, DEPT CLIN PHARMACOL, BEDFORD PK, SA 5042, AUSTRALIA
EICHELBAUM, M
SAWE, J
论文数:
0
引用数:
0
h-index:
0
机构:
FLINDERS UNIV S AUSTRALIA, DEPT CLIN PHARMACOL, BEDFORD PK, SA 5042, AUSTRALIA
SAWE, J
SJOQVIST, F
论文数:
0
引用数:
0
h-index:
0
机构:
FLINDERS UNIV S AUSTRALIA, DEPT CLIN PHARMACOL, BEDFORD PK, SA 5042, AUSTRALIA
SJOQVIST, F
[J].
CLINICAL PHARMACOLOGY & THERAPEUTICS,
1984,
35
(06)
: 815
-
821
[7]
DICKINSON TH, 1987, CLIN PHARMACOL THER, V41, P165
[8]
EFFECT OF ORAL-ADMINISTRATION OF A NEW CALCIUM-CHANNEL BLOCKING-AGENT, BEPRIDIL ON ANTIPYRINE CLEARANCE IN MAN
FUNCKBRENTANO, C
论文数:
0
引用数:
0
h-index:
0
FUNCKBRENTANO, C
CHAFFIN, PL
论文数:
0
引用数:
0
h-index:
0
CHAFFIN, PL
WILKINSON, GR
论文数:
0
引用数:
0
h-index:
0
WILKINSON, GR
MCALLISTER, B
论文数:
0
引用数:
0
h-index:
0
MCALLISTER, B
WOOSLEY, RL
论文数:
0
引用数:
0
h-index:
0
WOOSLEY, RL
[J].
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY,
1987,
24
(04)
: 559
-
560
[9]
NIFEDIPINE IN UNSTABLE ANGINA - A DOUBLE-BLIND, RANDOMIZED TRIAL
GERSTENBLITH, G
论文数:
0
引用数:
0
h-index:
0
GERSTENBLITH, G
OUYANG, P
论文数:
0
引用数:
0
h-index:
0
OUYANG, P
ACHUFF, SC
论文数:
0
引用数:
0
h-index:
0
ACHUFF, SC
BULKLEY, BH
论文数:
0
引用数:
0
h-index:
0
BULKLEY, BH
BECKER, LC
论文数:
0
引用数:
0
h-index:
0
BECKER, LC
MELLITS, ED
论文数:
0
引用数:
0
h-index:
0
MELLITS, ED
BAUGHMAN, KL
论文数:
0
引用数:
0
h-index:
0
BAUGHMAN, KL
WEISS, JL
论文数:
0
引用数:
0
h-index:
0
WEISS, JL
FLAHERTY, JT
论文数:
0
引用数:
0
h-index:
0
FLAHERTY, JT
KALLMAN, CH
论文数:
0
引用数:
0
h-index:
0
KALLMAN, CH
LLEWELLYN, M
论文数:
0
引用数:
0
h-index:
0
LLEWELLYN, M
WEISFELDT, ML
论文数:
0
引用数:
0
h-index:
0
WEISFELDT, ML
[J].
NEW ENGLAND JOURNAL OF MEDICINE,
1982,
306
(15)
: 885
-
889
[10]
GINSBURG R, 1982, AM HEART J, V103, P44, DOI 10.1016/0002-8703(82)90527-0
←
1
2
3
→
共 24 条
[1]
CHANGES IN ANTIPYRINE AND INDOCYANINE GREEN KINETICS DURING NIFEDIPINE, VERAPAMIL, AND DILTIAZEM THERAPY
BAUER, LA
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WASHINGTON,SCH MED,DEPT MED,DIV CARDIOL,SEATTLE,WA 98195
BAUER, LA
STENWALL, M
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WASHINGTON,SCH MED,DEPT MED,DIV CARDIOL,SEATTLE,WA 98195
STENWALL, M
HORN, JR
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WASHINGTON,SCH MED,DEPT MED,DIV CARDIOL,SEATTLE,WA 98195
HORN, JR
DAVIS, R
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WASHINGTON,SCH MED,DEPT MED,DIV CARDIOL,SEATTLE,WA 98195
DAVIS, R
OPHEIM, K
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WASHINGTON,SCH MED,DEPT MED,DIV CARDIOL,SEATTLE,WA 98195
OPHEIM, K
GREENE, L
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WASHINGTON,SCH MED,DEPT MED,DIV CARDIOL,SEATTLE,WA 98195
GREENE, L
[J].
CLINICAL PHARMACOLOGY & THERAPEUTICS,
1986,
40
(02)
: 239
-
242
[2]
COMPARISON OF THE INVIVO AND INVITRO RATES OF FORMATION OF THE 3 MAIN OXIDATIVE METABOLITES OF ANTIPYRINE IN MAN
BOOBIS, AR
论文数:
0
引用数:
0
h-index:
0
BOOBIS, AR
BRODIE, MJ
论文数:
0
引用数:
0
h-index:
0
BRODIE, MJ
KAHN, GC
论文数:
0
引用数:
0
h-index:
0
KAHN, GC
TOVERUD, EL
论文数:
0
引用数:
0
h-index:
0
TOVERUD, EL
BLAIR, IA
论文数:
0
引用数:
0
h-index:
0
BLAIR, IA
MURRAY, S
论文数:
0
引用数:
0
h-index:
0
MURRAY, S
DAVIES, DS
论文数:
0
引用数:
0
h-index:
0
DAVIES, DS
[J].
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY,
1981,
12
(06)
: 771
-
777
[3]
BREIMER DD, 1984, PHARMACOKINETICS MOD
[4]
DILTIAZEM TREATMENT IMPAIRS HEPATIC DRUG OXIDATION - STUDIES OF ANTIPYRINE
CARRUM, G
论文数:
0
引用数:
0
h-index:
0
机构:
BAYLOR COLL MED,DEPT MED,HYPERTENS & CLIN PHARMACOL SECT,1 BAYLOR PLAZA,SUITE 826E,HOUSTON,TX 77030
BAYLOR COLL MED,DEPT MED,HYPERTENS & CLIN PHARMACOL SECT,1 BAYLOR PLAZA,SUITE 826E,HOUSTON,TX 77030
CARRUM, G
EGAN, JM
论文数:
0
引用数:
0
h-index:
0
机构:
BAYLOR COLL MED,DEPT MED,HYPERTENS & CLIN PHARMACOL SECT,1 BAYLOR PLAZA,SUITE 826E,HOUSTON,TX 77030
BAYLOR COLL MED,DEPT MED,HYPERTENS & CLIN PHARMACOL SECT,1 BAYLOR PLAZA,SUITE 826E,HOUSTON,TX 77030
EGAN, JM
ABERNETHY, DR
论文数:
0
引用数:
0
h-index:
0
机构:
BAYLOR COLL MED,DEPT MED,HYPERTENS & CLIN PHARMACOL SECT,1 BAYLOR PLAZA,SUITE 826E,HOUSTON,TX 77030
BAYLOR COLL MED,DEPT MED,HYPERTENS & CLIN PHARMACOL SECT,1 BAYLOR PLAZA,SUITE 826E,HOUSTON,TX 77030
ABERNETHY, DR
[J].
CLINICAL PHARMACOLOGY & THERAPEUTICS,
1986,
40
(02)
: 140
-
143
[5]
A RANDOMIZED DOUBLE-BLIND CROSSOVER TRIAL OF NIFEDIPINE IN THE TREATMENT OF PRIMARY RAYNAUDS-PHENOMENON
CORBIN, DOC
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL INFIRM EDINBURGH,PERIPHERAL VASC CLIN,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
ROYAL INFIRM EDINBURGH,PERIPHERAL VASC CLIN,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
CORBIN, DOC
WOOD, DA
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL INFIRM EDINBURGH,PERIPHERAL VASC CLIN,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
ROYAL INFIRM EDINBURGH,PERIPHERAL VASC CLIN,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
WOOD, DA
MACINTYRE, CCA
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL INFIRM EDINBURGH,PERIPHERAL VASC CLIN,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
ROYAL INFIRM EDINBURGH,PERIPHERAL VASC CLIN,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
MACINTYRE, CCA
HOUSLEY, E
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL INFIRM EDINBURGH,PERIPHERAL VASC CLIN,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
ROYAL INFIRM EDINBURGH,PERIPHERAL VASC CLIN,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
HOUSLEY, E
[J].
EUROPEAN HEART JOURNAL,
1986,
7
(02)
: 165
-
170
[6]
THEOPHYLLINE METABOLISM IN RELATION TO ANTIPYRINE, DEBRISOQUINE, AND SPARTEINE METABOLISM
DAHLQVIST, R
论文数:
0
引用数:
0
h-index:
0
机构:
FLINDERS UNIV S AUSTRALIA, DEPT CLIN PHARMACOL, BEDFORD PK, SA 5042, AUSTRALIA
DAHLQVIST, R
BERTILSSON, L
论文数:
0
引用数:
0
h-index:
0
机构:
FLINDERS UNIV S AUSTRALIA, DEPT CLIN PHARMACOL, BEDFORD PK, SA 5042, AUSTRALIA
BERTILSSON, L
BIRKETT, DJ
论文数:
0
引用数:
0
h-index:
0
机构:
FLINDERS UNIV S AUSTRALIA, DEPT CLIN PHARMACOL, BEDFORD PK, SA 5042, AUSTRALIA
BIRKETT, DJ
EICHELBAUM, M
论文数:
0
引用数:
0
h-index:
0
机构:
FLINDERS UNIV S AUSTRALIA, DEPT CLIN PHARMACOL, BEDFORD PK, SA 5042, AUSTRALIA
EICHELBAUM, M
SAWE, J
论文数:
0
引用数:
0
h-index:
0
机构:
FLINDERS UNIV S AUSTRALIA, DEPT CLIN PHARMACOL, BEDFORD PK, SA 5042, AUSTRALIA
SAWE, J
SJOQVIST, F
论文数:
0
引用数:
0
h-index:
0
机构:
FLINDERS UNIV S AUSTRALIA, DEPT CLIN PHARMACOL, BEDFORD PK, SA 5042, AUSTRALIA
SJOQVIST, F
[J].
CLINICAL PHARMACOLOGY & THERAPEUTICS,
1984,
35
(06)
: 815
-
821
[7]
DICKINSON TH, 1987, CLIN PHARMACOL THER, V41, P165
[8]
EFFECT OF ORAL-ADMINISTRATION OF A NEW CALCIUM-CHANNEL BLOCKING-AGENT, BEPRIDIL ON ANTIPYRINE CLEARANCE IN MAN
FUNCKBRENTANO, C
论文数:
0
引用数:
0
h-index:
0
FUNCKBRENTANO, C
CHAFFIN, PL
论文数:
0
引用数:
0
h-index:
0
CHAFFIN, PL
WILKINSON, GR
论文数:
0
引用数:
0
h-index:
0
WILKINSON, GR
MCALLISTER, B
论文数:
0
引用数:
0
h-index:
0
MCALLISTER, B
WOOSLEY, RL
论文数:
0
引用数:
0
h-index:
0
WOOSLEY, RL
[J].
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY,
1987,
24
(04)
: 559
-
560
[9]
NIFEDIPINE IN UNSTABLE ANGINA - A DOUBLE-BLIND, RANDOMIZED TRIAL
GERSTENBLITH, G
论文数:
0
引用数:
0
h-index:
0
GERSTENBLITH, G
OUYANG, P
论文数:
0
引用数:
0
h-index:
0
OUYANG, P
ACHUFF, SC
论文数:
0
引用数:
0
h-index:
0
ACHUFF, SC
BULKLEY, BH
论文数:
0
引用数:
0
h-index:
0
BULKLEY, BH
BECKER, LC
论文数:
0
引用数:
0
h-index:
0
BECKER, LC
MELLITS, ED
论文数:
0
引用数:
0
h-index:
0
MELLITS, ED
BAUGHMAN, KL
论文数:
0
引用数:
0
h-index:
0
BAUGHMAN, KL
WEISS, JL
论文数:
0
引用数:
0
h-index:
0
WEISS, JL
FLAHERTY, JT
论文数:
0
引用数:
0
h-index:
0
FLAHERTY, JT
KALLMAN, CH
论文数:
0
引用数:
0
h-index:
0
KALLMAN, CH
LLEWELLYN, M
论文数:
0
引用数:
0
h-index:
0
LLEWELLYN, M
WEISFELDT, ML
论文数:
0
引用数:
0
h-index:
0
WEISFELDT, ML
[J].
NEW ENGLAND JOURNAL OF MEDICINE,
1982,
306
(15)
: 885
-
889
[10]
GINSBURG R, 1982, AM HEART J, V103, P44, DOI 10.1016/0002-8703(82)90527-0
←
1
2
3
→